Subjective effects as predictors of substance use disorders in a clinical sample: A longitudinal study
- PMID: 37331303
- PMCID: PMC10851615
- DOI: 10.1016/j.drugalcdep.2023.110822
Subjective effects as predictors of substance use disorders in a clinical sample: A longitudinal study
Abstract
Background: The literature on the association between subjective effects (SEs; i.e., how an individual perceives their physiological and psychological reactions to a drug) and substance use disorders (SUDs) is largely limited to community samples. The present study addressed the following aims in a clinical sample: whether SEs predict general versus substance-specific SUD in adolescence and adulthood after controlling for conduct disorder symptoms (CDsymp); whether SEs predict SUDs across drug classes; whether SEs predict change in SUD from adolescence to adulthood; and whether there are racial/ethnic differences in associations.
Methods: Longitudinal analyses were conducted using data from a sample of 744 clinical probands recruited from residential and outpatient SUD treatment facilities in CO during adolescence (Mage = 16.26) and re-assessed twice in adulthood (Mages = 22.56 and 28.96), approximately seven and twelve years after first assessment. SEs and CDsymp were assessed in adolescence. SUD severity was assessed at adolescence and twice during adulthood.
Results: SEs assessed in adolescence robustly predicted general SUD for legal and illegal substances in adolescence and adulthood, whereas CDsymp predicted SUD primarily in adolescence. Higher positive and negative SEs in adolescence were associated with greater SUD severity after controlling for CDsymp, with similar magnitudes. Results indicated cross-substance effects of SEs on SUD. We found no evidence for racial/ethnic differences in associations.
Conclusions: We investigated the progression of SUD in a high-risk sample with greater odds of sustained SUD. In contrast to CDsymp, both positive and negative SEs consistently predicted general SUD across substances in adolescence and adulthood.
Keywords: Adolescents; Adults; Clinical sample; Conduct disorder; Longitudinal; Polysubstance use; Subjective effects; Substance use disorder.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest No conflict declared.
Figures



Similar articles
-
Do Substances Used in Adolescence Predict the Persistence of Substance Use Disorders in Adulthood? A 15-Year Study of Youth After Detention.J Adolesc Health. 2025 Feb;76(2):210-219. doi: 10.1016/j.jadohealth.2024.04.019. Epub 2024 Jun 22. J Adolesc Health. 2025. PMID: 38912979
-
Longitudinal Analysis of Substance Use Disorder Symptom Severity at Age 18 Years and Substance Use Disorder in Adulthood.JAMA Netw Open. 2022 Apr 1;5(4):e225324. doi: 10.1001/jamanetworkopen.2022.5324. JAMA Netw Open. 2022. PMID: 35363270 Free PMC article.
-
Independent predictors of mortality in adolescents ascertained for conduct disorder and substance use problems, their siblings and community controls.Addiction. 2018 Nov;113(11):2107-2115. doi: 10.1111/add.14366. Epub 2018 Aug 9. Addiction. 2018. PMID: 30091161 Free PMC article.
-
A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908x280707. Epub 2008 Apr 1. Curr Med Res Opin. 2008. PMID: 18384709 Review.
-
Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention.J Clin Psychiatry. 2010 Mar;71(3):348-58. doi: 10.4088/JCP.09r05222gry. Epub 2009 Dec 1. J Clin Psychiatry. 2010. PMID: 19961811 Review.
Cited by
-
Prescription Opioid Medication Survey: A Tool to Collect Deep Phenotypic Data on the Multifactorial Pathways to Opioid Use Disorder in Clinical and Population-Based Cohorts.Complex Psychiatry. 2025 May 17;11(1):72-93. doi: 10.1159/000546389. eCollection 2025 Jan-Dec. Complex Psychiatry. 2025. PMID: 40621581
References
-
- Benjamini Y, & Hochberg Y (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological), 57(1), 289–300. JSTOR.
-
- Bieber CM, Fernandez K, Borsook D, Brennan MJ, Butler SF, Jamison RN, Osgood E, Sharpe-Potter J, Thomson HN, Weiss RD, & Katz NP (2008). Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: A pilot case-control study. Experimental and Clinical Psychopharmacology, 16(5), 429–434. 10.1037/1064-1297.16.5.429 - DOI - PMC - PubMed
-
- Border R, Corley RP, Brown SA, Hewitt JK, Hopfer CJ, McWilliams SK, Rhea SA, Shriver CL, Stallings MC, Wall TL, Woodward KE, & Rhee SH (2018). Independent predictors of mortality in adolescents ascertained for conduct disorder and substance use problems, their siblings and community controls. Addiction (Abingdon, England), 113(11), Article 11. 10.1111/add.14366 - DOI - PMC - PubMed